Focused review articles

Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?

EuroIntervention 2013;9:S43-S47. DOI: 10.4244/EIJV9SSA9

Jean-Philippe Collet
Jean-Philippe Collet, MD, PhD; Gilles Montalescot, MD, PhD
Institut de Cardiologie - INSERM U 937 - Groupe A.C.T.I.O.N., Groupe Hospitalier Pitié-Salpêtrière and Université Pierre et Marie Curie, Paris, France

Guidelines on antithrombotic therapy after TAVI are scarce and no randomised evaluation has been performed to demonstrate what the best strategy is. Extrapolation from what we know on surgical heart valve replacement is also

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

antiplatelet agentsbleedingplateletsstroketranscatheter aortic valve implantation
Read next article
Cost-effectiveness of transcatheter valvular interventions: economic challenges

Latest news